Search clinical trials for: Alimta (Pemetrexed)
Total 1198 results
-
University of California, DavisNovartis PharmaceuticalsCompletedSolid Tumors | Non-Small Cell Lung Cancer (NSCLC)United States
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CarcinomaArgentina, Israel, United States, Spain, Germany, Belgium, Italy, Brazil, France, Canada, Netherlands, Turkey
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CancerGermany
-
H. Lee Moffitt Cancer Center and Research InstituteSanofiTerminatedPemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant ChemLung CancerUnited States
-
SCRI Development Innovations, LLCEli Lilly and CompanyCompletedNon Small Cell Lung CancerUnited States
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung CancerChina, Italy, Australia, Poland, Netherlands, India, Austria, Spain, Bulgaria, United States, Greece, Turkey, Brazil, Croatia, Czech Republic, Germany, Hungary, Korea, Republic of, Romania, Taiwan
-
NovoCure Ltd.CompletedNSCLC | Non-small Cell Lung CancerSwitzerland
-
Fox Chase Cancer CenterEli Lilly and CompanyTerminatedHead and Neck CancerUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); North Central Cancer Treatment GroupCompletedPemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural MesotheliomaMesotheliomaUnited States
-
Dartmouth-Hitchcock Medical CenterCTI BioPharmaCompletedAdvanced Non-small Cell Lung CancerUnited States
-
Baohui HanCompleted
-
AstraZenecaCompletedNon-small Cell Lung CancerUnited States, Bulgaria, Romania
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerSpain, Italy, Germany, France
-
Tang-Du HospitalUnknown
-
University of ChicagoBristol-Myers SquibbTerminatedNon-small Cell Lung CancerUnited States
-
Dutch Society of Physicians for Pulmonology and...CompletedCarcinoma, Non-Small-Cell LungNetherlands
-
Si-Yu WangCompleted
-
PfizerCompletedNeoplasm, MalignantJapan
-
Eli Lilly and CompanyCompletedBreast CancerAustria, Czech Republic, Hungary, Poland, Romania, Russian Federation
-
Duke UniversityEli Lilly and CompanyTerminatedCarcinoma, Non-Small-Cell LungUnited States
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CancerSpain, Netherlands, Austria, Greece, Germany, Italy
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerChina, Korea, Republic of, Taiwan
-
Samsung Medical CenterUnknownNon-small Cell Lung CancerKorea, Republic of
-
Eli Lilly and CompanyCompletedBreast Cancer | Breast NeoplasmsUnited States, Puerto Rico
-
University Health Network, TorontoNovartis PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterEli Lilly and CompanyCompletedLung CancerUnited States
-
Shirish M GadgeelAstraZeneca; Henry Ford Health SystemWithdrawnLung Cancer | Non-small Cell Lung Cancer | PD-L1 Gene Mutation | KRAS Activating MutationUnited States
-
AIO-Studien-gGmbHBoehringer IngelheimTerminatedNon-small-cell Lung Cancer With Somatic EGFR MutationsGermany
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerTaiwan, Korea, Republic of, Singapore, Thailand, Hong Kong
-
Instituto Nacional de Cancer, BrazilEli Lilly and CompanyCompletedNon Small Cell Lung CarcinomaBrazil, United States
-
Armando Santoro, MDCompleted
-
Eli Lilly and CompanyCompletedNeoplasms | Carcinoma, Non-Small-Cell Lung | Lung NeoplasmsUnited States
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CarcinomaBelgium, France, Germany, Portugal, Spain, Sweden, Italy, United States, Canada, Netherlands, Argentina, Australia, Austria, Brazil, Denmark, Finland, Greece, Hungary, India, Israel, Korea, Republic of, Mexico, Poland, Puerto Rico, Taiwan, Turk... and more
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
Peking Union Medical College HospitalUnknownNon Small Cell Lung CancerChina
-
Incyte CorporationTerminatedNSCLC (Non-small Cell Lung Carcinoma)United States
-
AstraZenecaTerminatedSolid Tumors | Advanced Solid Malignancies | Cancer,United States
-
Duke UniversityEli Lilly and CompanyTerminatedNon Small Cell Lung CancerUnited States
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Eli Lilly and CompanyCompletedCarcinoma, Non Small Cell LungTaiwan, Japan, Korea, Republic of, China
-
WiSP Wissenschaftlicher Service Pharma GmbHGesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbHSuspendedCarcinoma, Non-Small-Cell LungGermany
-
Saint John's Cancer InstituteEli Lilly and Company; Chordoma FoundationCompleted
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedHistological or Cytological Diagnosis of Locally Advanced or Metastatic NSCLC of Nonsquamous Histology and Not Amenable to Curative Therapy.Hungary, Germany, Austria, Spain, Sweden
-
Queen Mary University of LondonHoffmann-La Roche; Polaris GroupWithdrawnCarcinoma, Non-Small-Cell Lung
-
SCRI Development Innovations, LLCAmgenCompletedNon-Small-Cell Lung CancerUnited States
-
Hellenic Oncology Research GroupUniversity Hospital of CreteCompletedNon Small Cell Lung CancerGreece
-
University of California, DavisEli Lilly and Company; CelgeneTerminatedBreast Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Hospital Organization Nagoya Medical CenterMerck Sharp & Dohme LLC; Central Japan Lung Study GroupActive, not recruitingNon-squamous Non-small-cell Lung Cancer | Cancer, LungJapan
-
Gachon University Gil Medical CenterCompletedPrevious Treated Metastatic Non-small Cell Lung CancerKorea, Republic of